drugset / Trial / NCT04620031

A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation

NCT04620031

Phase 3 Completed 135 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a multi-center, randomized, single-blind, propofol-controlled phase III clinical study. In this study, ICU patients undergoing mechanical ventilation are expected to be enrolled and will be randomly assigned to the HSK3486 group and the propofol group.

Timeline

Start
2020-12-08
Primary completion
2021-06-02
Completion
2021-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.3 mg/kg Intravenous
Comparator Propofol Small molecule 1.5 mg/kg Intravenous

Indications

No indication recorded.